New Medtronic Implantable Cardiac Monitor Gives Physicians Valuable Insights into the Cause of Unexplained Fainting

Medtronic, Inc. (NYSE:MDT) announced the European introduction of the Reveal(R) DX, a new Insertable Cardiac Monitor that offers diagnostic and monitoring information related to syncope (fainting) in patients. The device recently received CE (Conformite Europeenne) Mark, and the first implant of Reveal DX took place at Ospedali del Tigullio in Lavagna, Italy, by Prof. Michele Brignole, M.D. Placed just under the skin of the chest area using local anesthesia during a simple outpatient procedure, the monitor records important data before, during and after a syncopal event. This data enables the physician to diagnose the patient and determine the right treatment based on long-term cardiac...

Want to see the full article?

• Purchase this article for only $3.00